David Drapkin Talks SPACs with Nasdaq’s Jill Malandrino

by | Jan 21, 2022

Boardroom Alpha’s David Drapkin recently joined Jill Malandrino on Nasdaq Trade Talks to discuss SPACs. Watch the video or jump below for some quick brief bullets.

Quick Brief

  • 2021 was a watershed year in SPACs. Both market activity and hype obliterated the historical volume for the asset class and the big, fast shifts in sentiment and trades happened throughout the year.
  • 2022 will also see a lot of activity and big, fast shifts in sentiment, and creativity, but instead of massive IPO issuance we’re expecting – and the market needs – a lot of deals, liquidations, and slower IPO pacing 
  • There are too many SPACs in the market right now and by ’22Q4 there could be over 300 SPACs over 12 months old looking for deals
  • “Peak Deal” is a big concern going forward. Given the need to complete a deal or liquidate, will sponsors overreach and bring increasingly bad deals to the market?
  • Getting IPOs done has been increasingly costly for sponsors (e.g. overfunding trusts, better warrants, etc), but it still remains very profitable and so they have incentives to continue issuing
  • “One-and-done” SPAC sponsors will be culled and pay a higher price than trusted serial sponsors whom investors will start to strongly prefer.
  • DeSPACs are stuck in a bad (very bad) rut and only a good run of very strong deals and strong post deSPAC trading will change that.

3 Take Aways for SPAC Investors

  1. SPACs are here to stay and can be a profitable trade if they know the plays and are on top of the details 
  2. Watch for SPACs with trusted sponsors that offer yield and potential upside 
  3. The SPAC market can change quickly and 2022 will see some big, fast changes that will present both risks and opportunities for investors, therefore it is critical to have the right tools to support your strategy 

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

SPAC Market Review – April 2022

The market is a mess right now. A hawkish Fed and even more cautious SEC are slowing deals….but may raise the bar for more quality SPACs down the line.

SPAC Market Review – March 2022

Despite increased scrutiny and apparent investor fatigue, deals are getting done and SPACs remain an attractive path to the public markets.

SPAC Research & Analysis

Starting the Week with 2 DAs

Starting the week off with 2 DAs– oil & gas and battery tech. And the rest of the day’s news in SPACs.

Comera Gets Approval, with Over 98% Redemptions

Squeeze alert: OTRA approves its merger with Comera Life Sciences, albeit with some of highest redemptions we’ve seen in a while (98.4%). And the rest of the day’s news in SPACs.

Know Who Drives Return Podcast

NYC Pension Funds Want Amazon Accountable for Human Capital

AMZN stock is performing, but are warehouse workers paying the price? We talk to Assistant NYC Comptroller Michael Garland on the NYC Pension Funds’ move to unseat two Amazon board members responsible for human capital management at the tech giant.

Boardroom Alpha Daily Read

Board blow-up at Redbox Entertainment. Mill Road Capital Pushing for a Sale of Big Lots. Happy Earth Day! A perfect time to tune into our latest ESG podcast.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.